Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/9350
Share/Export:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Title

The many faces of VIP in neuroimmunology: a cytokine rather a neuropeptide?

AuthorsPozo Pérez, David; Delgado, M.
KeywordsImmune response
Autoimmunity
Th cells
Vasoactive intestinal peptide
Issue DateSep-2004
PublisherFederation of American Societies for Experimental Biology
CitationThe FASEB Journal 18: 1325-1334 (2004)
AbstractNeuroimmunomodulation has experienced an explosive growth not only in basic research, but expanding to the point that prospective clinical research could be now a reality. A crucial factor for the functioning of this intimate bidirectional network was the demonstration that the immune and neuroendocrine systems speak a mutual biochemical language. This implies 1) production of neuroendocrine hormones and neuropeptides by immune cells and of cytokines by neuroendocrine cells; 2) evidence for shared receptors on cells of the immune and neuroendocrine systems; 3) effect of neuroendocrine mediators on immune functions; and 4) effect of cytokines on the neuroendocrine system. This reduces traditional differences between neurotransmitters, hormones, and immune mediators and raises the following question: what can we now regard as immune or neuroendocrine? Vasoactive intestinal peptide (VIP) is one example of this paradigm. VIP has traditionally been classified as a neuropeptide/neurotransmitter based in its capacity to mediate and regulate neuronal functions. Recent work has demonstrated that VIP is produced by T cells, especially Th2 cells, and that through specific receptors it exerts immunological functions typically ascribed to Th2 cytokines in nervous and immune systems. Here, we postulate that instead of a neuropeptide, VIP could be fully considered a type 2 cytokine with a key role in neuroimmunology.
Description10 pages, 3 figures.-- PMID: 15333575 [PubMed].
Publisher version (URL)http://dx.doi.org/10.1096/fj.03-1440hyp
URIhttp://hdl.handle.net/10261/9350
DOI10.1096/fj.03-1440hyp
ISSN0892-6638
Appears in Collections:(IPBLN) Artículos




Files in This Item:
File Description SizeFormat
Pozo_Delgado_FASEB_Journal_2004.pdf2,16 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work

SCOPUSTM   
Citations

79
checked on Jun 27, 2022

WEB OF SCIENCETM
Citations

72
checked on Jul 1, 2022

Page view(s)

345
checked on Jul 5, 2022

Download(s)

349
checked on Jul 5, 2022

Google ScholarTM

Check

Altmetric

Dimensions


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.